Valuation: MindMaze Therapeutics Holding SA

Market Cap 28.99M 36.18M 30.99M 26.54M 49.81M 3.46B 50.47M 343M 134M 1.74B 136M 133M 5.75B P/E 2026 *
-4.75x
P/E 2027 * 1.36x
Enterprise Value 20.58M 25.67M 21.99M 18.83M 35.35M 2.46B 35.81M 243M 94.8M 1.23B 96.39M 94.3M 4.08B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 0.23x
Free-Float
38.51%
Yield 2026 *
-
Yield 2027 * -
1 day+0.11%
1 week-17.03%
Current month-4.62%
1 month+20.41%
3 months-57.30%
6 months-79.96%
Current year-90.00%
1 week 0.18
Extreme 0.185
0.25
1 month 0.15
Extreme 0.1526
0.28
Current year 0.15
Extreme 0.1518
1.87
1 year 0.15
Extreme 0.1518
2.92
3 years 0.15
Extreme 0.1518
2.92
5 years 0.15
Extreme 0.1518
2.92
10 years 0.15
Extreme 0.1518
2.92
Date Insider Type Main position Quantity % Market Cap.
12/19/25 Sell 140,000 0.0908%
12/19/25 Sell 52,162 0.0338%
12/19/25 Sell 281,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-17.03% - - 36.18M
+1.09%+5.26%+4.52%+26.24% 51.61B
-1.07%+2.82%+465.96%+586.75% 44.89B
+1.47%+9.79%+35.92%+21.40% 42.77B
+1.44%+7.77%+19.38%+92.75% 42.58B
-0.93%-4.33%+16.18%+53.76% 31.82B
+1.32%+7.30%+33.89%+150.10% 17.33B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+6.55%+32.10% 14.76B
+1.28%+5.41%+82.40%+47.43% 14.09B
Average +0.41%+2.29%+83.10%+126.32% 27.65B
Weighted average by Cap. +0.49%+4.71%+99.57%+146.30%

Financials

2026 *2027 *
Net sales 5.9M 7.36M 6.31M 5.4M 10.14M 704M 10.27M 69.71M 27.18M 354M 27.64M 27.04M 1.17B 43.2M 53.9M 46.17M 39.54M 74.21M 5.16B 75.19M 510M 199M 2.59B 202M 198M 8.57B
Net income -7.81M -9.75M -8.35M -7.15M -13.42M -932M -13.6M -92.28M -35.99M -468M -36.59M -35.8M -1.55B 24.83M 30.98M 26.53M 22.73M 42.65M 2.96B 43.21M 293M 114M 1.49B 116M 114M 4.92B
Net Debt -8.42M -10.5M -9M -7.71M -14.46M -1.01B -14.65M -99.47M -38.79M -505M -39.44M -38.58M -1.67B -19.27M -24.04M -20.59M -17.64M -33.1M -2.3B -33.54M -228M -88.78M -1.16B -90.27M -88.31M -3.82B
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
-
Date Price Change Volume
26-08-21 CHF 0.1900 +0.11% 1,113,425
26-08-20 CHF 0.1898 -8.97% 1,821,062
26-08-19 CHF 0.2085 +1.71% 561,564
26-08-18 CHF 0.2050 -9.89% 787,779
26-08-17 CHF 0.2275 -0.66% 652,329
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise